Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART
From MaRDI portal
Publication:263546
DOI10.1016/j.bulm.2005.01.006zbMath1334.92407arXivq-bio/0411040OpenAlexW2145283309WikidataQ51968968 ScholiaQ51968968MaRDI QIDQ263546
Laura E. Jonesa, Alan S. Perelson
Publication date: 5 April 2016
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/q-bio/0411040
Related Items (16)
Modeling HIV persistence, the latent reservoir, and viral blips ⋮ Stochastic modelling of viral blips in HIV-1-infected patients: effects of inhomogeneous density fluctuations ⋮ Backward bifurcations, turning points and rich dynamics in simple disease models ⋮ Parameter Selection Methods in Inverse Problem Formulation ⋮ A model for HCMV infection in immunosuppressed patients ⋮ Alternating host cell tropism shapes the persistence, evolution and coexistence of Epstein-Barr virus infections in human ⋮ Mutation and control of the human immunodeficiency virus ⋮ Impact of latently infected cells on strain archiving within HIV hosts ⋮ Dynamical analysis of antigen-driven t-cell infection model with multiple delays ⋮ Excitability in the host-pathogen interactions of HIV infection and emergence of viral load blips ⋮ A mathematical model of HIV infection: Simulating T4, T8 macrophages, antibody, and virus via specific anti-HIV response in the presence of adaptation and tropism ⋮ Superinfection with a heterologous HIV strain per se does not lead to faster progression ⋮ Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy ⋮ Quantifying T lymphocyte turnover ⋮ Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips ⋮ Modelling HIV immune response and validation with clinical data
This page was built for publication: Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART
